Astena Group's Spera Pharma and Spera Nexus to Exhibit at 'CPHI Japan 2026'
Astena Group's Spera Pharma and Spera Nexus will exhibit at the international pharmaceutical and healthcare exhibition 'CPHI Japan 2026'. The group promotes ESG management centered on five businesses.
📋 Article Processing Timeline
- 📰 Published: April 17, 2026 at 16:20
- 🔍 Collected: April 17, 2026 at 17:01 (41 min after Published)
- 🤖 AI Analyzed: April 18, 2026 at 20:40 (27h 38m after Collected)
Astena Group announces that its subsidiaries Spera Pharma and Spera Nexus will exhibit at 'CPHI Japan 2026', to be held in 2026. This exhibition is an international event gathering the latest technologies and products in the pharmaceutical and healthcare industries. Astena Group transitioned to a holding company structure on June 1, 2021, and aims for sustainable growth through ESG management and investment in new businesses, with five core businesses: fine chemicals, pharmaceuticals, HBC food, chemical products, and social impact.